
### [NCIT:C7376](http://purl.obolibrary.org/obo/NCIT_C7376)
**Label:** Pleural Malignant Mesothelioma

**Subclasses:** [NCIT:C6648](http://purl.obolibrary.org/obo/NCIT_C6648) (Stage III Pleural Malignant Mesothelioma AJCC v7), [NCIT:C136403](http://purl.obolibrary.org/obo/NCIT_C136403) (Stage III Pleural Malignant Mesothelioma AJCC v8), [NCIT:C8707](http://purl.obolibrary.org/obo/NCIT_C8707) (Recurrent Pleural Malignant Mesothelioma), [NCIT:C6647](http://purl.obolibrary.org/obo/NCIT_C6647) (Stage II Pleural Malignant Mesothelioma AJCC v7), [NCIT:C136399](http://purl.obolibrary.org/obo/NCIT_C136399) (Pleural Malignant Mesothelioma by AJCC v8 Stage), [NCIT:C6649](http://purl.obolibrary.org/obo/NCIT_C6649) (Stage IV Pleural Malignant Mesothelioma AJCC v7), [NCIT:C136406](http://purl.obolibrary.org/obo/NCIT_C136406) (Stage IV Pleural Malignant Mesothelioma AJCC v8), [NCIT:C136400](http://purl.obolibrary.org/obo/NCIT_C136400) (Stage I Pleural Malignant Mesothelioma AJCC v8), [NCIT:C6646](http://purl.obolibrary.org/obo/NCIT_C6646) (Stage I Pleural Malignant Mesothelioma AJCC v7), [NCIT:C136402](http://purl.obolibrary.org/obo/NCIT_C136402) (Stage II Pleural Malignant Mesothelioma AJCC v8), [NCIT:C45663](http://purl.obolibrary.org/obo/NCIT_C45663) (Pleural Sarcomatoid Mesothelioma), [NCIT:C45662](http://purl.obolibrary.org/obo/NCIT_C45662) (Pleural Epithelioid Mesothelioma), [NCIT:C45665](http://purl.obolibrary.org/obo/NCIT_C45665) (Pleural Biphasic Mesothelioma), [NCIT:C45664](http://purl.obolibrary.org/obo/NCIT_C45664) (Pleural Desmoplastic Mesothelioma), [NCIT:C45666](http://purl.obolibrary.org/obo/NCIT_C45666) (Localized Pleural Malignant Mesothelioma), [NCIT:C136374](http://purl.obolibrary.org/obo/NCIT_C136374) (Pleural Malignant Mesothelioma by AJCC v7 Stage), 

**Class expressions from DL-Learner:**

- Thing 54.67%
- [NCIT:C45669](http://purl.obolibrary.org/obo/NCIT_C45669) (NF2 Gene Mutation) 51.47%
- [NCIT:C45668](http://purl.obolibrary.org/obo/NCIT_C45668) (GPC3 Gene Inactivation) 51.47%
- [NCIT:C39629](http://purl.obolibrary.org/obo/NCIT_C39629) (CDKN2A Gene Inactivation) 51.47%
- [NCIT:C36597](http://purl.obolibrary.org/obo/NCIT_C36597) (Loss of Chromosome 1) 51.47%
- [NCIT:C36586](http://purl.obolibrary.org/obo/NCIT_C36586) (Loss of Chromosome 3) 51.47%
- [NCIT:C36584](http://purl.obolibrary.org/obo/NCIT_C36584) (Loss of Chromosome 9) 51.47%
- [NCIT:C36550](http://purl.obolibrary.org/obo/NCIT_C36550) (Gain of Chromosome 7p) 51.47%
- [NCIT:C36499](http://purl.obolibrary.org/obo/NCIT_C36499) (Loss of Chromosome 17p) 51.47%
- [NCIT:C36489](http://purl.obolibrary.org/obo/NCIT_C36489) (Gain of Chromosome 5p) 51.47%
- [NCIT:C36488](http://purl.obolibrary.org/obo/NCIT_C36488) (Gain of Chromosome 8q) 51.47%
- [NCIT:C36482](http://purl.obolibrary.org/obo/NCIT_C36482) (Gain of Chromosome 1q) 51.47%
- [NCIT:C36481](http://purl.obolibrary.org/obo/NCIT_C36481) (Gain of Chromosome 15q) 51.47%
- [NCIT:C36461](http://purl.obolibrary.org/obo/NCIT_C36461) (Monosomy 22) 51.47%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) 36.83%


